Bladder Cancer: Diagnosis, Therapeutics, and Management

ISBN-13: 9781617796616 / Angielski / Miękka / 2012 / 330 str.

Lee, Cheryl T.

Opis

In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cancer care. Their work aims to spur innovative thoughts and approaches to common problems in the management of early stage and advanced disease. The book discusses at length the state of bladder cancer staging and the optimal treatment for localized disease. Additional sections review the applications of existing systemic therapies and look at the infrastructure needed to support translational research efforts. Groundbreaking and authoritative, Bladder Cancer: Moving the Field Forward, is the definitive text on the current state of bladder cancer care and a must have for all urologists and medical oncologists who wish to provide their patients with the most comprehensive care.

Recenzje

From the reviews: "This is a summation of the active issues involved in the diagnosis and treatment of bladder urothelial carcinoma (UC). ... comprehensive guide to current standards of care and emerging technologies ... . medical oncologists should also strongly consider adding this to their libraries. Residents would benefit from this book ... . valuable addition to the library of any practicing urologist. The authors strive, successfully, to provide the latest data based on high levels of evidence ... in the diagnosis, management, and eradication of bladder cancer." (Deborah Tova Glassman, Doody's Review Service, March, 2010)

Spis treści

Part I. Improving Bladder Cancer Staging Section 1. CIS Chapter 1. Approach to CIS J. Stephen Jones, MD Chapter 2. Fluorescent Cystoscopy H. Barton Grossman, MD Section 2. Understaging Chapter 3. Restaging TURBT Jeffrey Holzberlein, MD Chapter 4. Understaging T2: Limitations of Pelvic Imaging Richard Cohan, MD Chapter 5. MRI Endorectal Coil Saroja Adusumilli, MD Chapter 6. PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease Morand Piert, MD Chapter 7. Detection of Extravesical Disease: A Lack of Bladder Cancer Markers Sam S. Chang, MD Chapter 8. Identification of Nodal Metastases: The Role of Iron Oxide Enhanced MRI Bernard Bochner, MD Chapter 9. Presence and Significance of Micrometastases Douglas Scher, MD Part II. Optimizing Treatment of Localized Disease Section 1: Intravesical Therapy Chapter 10. Peri-operative intravesical therapy Ed Messing, MD Chapter 11. BCG Refractory Disease Graham Greene, MD Chapter 12. Beyond BCG: Gemcitabine Guido Dalbagni, MD Chapter 13. Beyond BCG: Taxanes James McKiernan, MD Section 2: Cystectomy: Cancer Control and Organ Preservation Chapter 14. Extended Lymph Node Dissection Marcus Quek, MD Chapter 15. Prostate Capsule Sparing Cystectomy Alon Weizer, MD Chapter 16. Preservation of Reproductive Organs in Women Gary Steinberg, MD Chapter 17. Nerve Sparing Cystectomy Mark Schoenberg, MD Chapter 18. Quality of Care Indicators for Radical Cystectomy Badrinath R. Konety, MBBS, MBA Section 3: Continent Diversion: Problems and Solutions Chapter 19. Continent Diversion: QOL of Orthotopic Diversion vs Ileal Conduit Scott Gilbert, MD Chapter 20. Voiding Dysfunction After Orthotopic Diversion Jerilyn Latini, MD Chapter 21. Overcoming the Stigma of Complications of Continent Cutaneous Diversion Tom Gardner, MD Part III. Locally Advanced / Distant Disease: Multi-Modality treatment Chapter 22. Neoadjuvant Chemotherapy: The New Standard Primo Lara, MD Chapter 23. Adjuvant Therapy: A Good Concept But Where’s the Proof Timothy Gilligan, MD Chapter 24. Beyond MVAC: New and Improved Chemotherapeutics Maha Hussain, MD Part IV: Next Steps: Translational Research Chapter 25. The Role of Microarray Technologies in Bladder Cancer Management Marta Sanchez-Carbayo, PhD Chapter 26. Development of Novel Agents / Targeted Therapies Dan Theodorescu, MD Chapter 27. Tools for Study: National Databanking Randall Miliken, MD Chapter 28. Vaccine Development John Coleman, MD Chapter 29. Advances in Gene Therapy for Bladder Cancer Tom Gardner, MD